Eli Lilly and Co (HAM:LLY) Total Liabilities: €73,852 Mil (As of Mar. 2026)


HAM:LLY Eli Lilly and Co HAM:LLY
98 GF Score
Price €1,081.20
GF Value €1,239.15
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eli Lilly and Co Total Liabilities?

Eli Lilly and Co HAM:LLY +4.02% 98 Total Liabilities is €73,852 Mil as of Mar. 2026. GuruFocus rates HAM:LLY with a GF Score™ of 98/100 and a GF Value™ of €1,239.15 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Eli Lilly and Co's Total Liabilities for the quarter that ended in Mar. 2026 was €73,852 Mil.

Eli Lilly and Co's quarterly Total Liabilities declined from Sep. 2025 (€77,604.08 Mil) to Dec. 2025 (€73,393.61 Mil) but then increased from Dec. 2025 (€73,393.61 Mil) to Mar. 2026 (€73,851.97 Mil).

Eli Lilly and Co's annual Total Liabilities increased from Dec. 2023 (€48,731.76 Mil) to Dec. 2024 (€61,543.07 Mil) and increased from Dec. 2024 (€61,543.07 Mil) to Dec. 2025 (€73,393.61 Mil).

Eli Lilly and Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Total Liabilities Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35,091.31 36,546.39 48,731.76 61,543.07 73,393.61

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68,026.35 71,591.22 77,604.08 73,393.61 73,851.97
HAM:LLY
98GF Score
Eli Lilly and Co HAM:LLY
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eli Lilly and Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=30084.712+(34901.272+3390.38
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+5017.25)
=73,394

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=96054.504-22660.89
=73,394

Eli Lilly and Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=31688.41+(34055.05+3533.525
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+5017.25)
=73,852

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=100838.24-26986.27
=73,852

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €73,852 Mil mean?
Eli Lilly and Co (HAM:LLY) has a Total Liabilities of €73,852 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Total Liabilities too high?
Eli Lilly and Co's current Total Liabilities is €73,852 Mil. Overall, Eli Lilly and Co has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Total Liabilities compare to JNJ and ABBV?
Eli Lilly and Co's Total Liabilities of €73,852 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eli Lilly and Co and its competitors. Eli Lilly and Co's current Total Liabilities is €73,852 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (HAM:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is €1,239.15, compared to a current price of €1,081.20 — trading 12.7% below its estimated fair value. The current Total Liabilities is €73,852 Mil. Eli Lilly and Co's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Eli Lilly and Co (HAM:LLY), the current Total Liabilities is €73,852 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (HAM:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €1,081.20 is trading 12.7% below its estimated GF Value™ of €1,239.15. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for HAM:LLY:

  • Total Liabilities: €73,852 Mil
  • GF Value™: €1,239.15 vs. price of €1,081.20 (12.7% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the HAM:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
98GF Score

Get the complete analysis for HAM:LLY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1,081.20
Price
€1,239.15
GF Value